THE WORLD’S FIRST PRACTICAL METHOD FOR MEASURING THE BRAIN FUNCTION OF INTENSIVE CARE PATIENTS

INTRODUCING A NEW METHOD TO READ
THE PULSE OF THE BRAIN

Our CERENION C-TREND™ technology (pat. pend.) reveals the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient.

From strong science
to better healthcare

CERENION C-TREND™ offers the first truly objective and practical method to obtain reliable information on the condition and function of the brain. The clinically validated measure can be integrated into EEG-measurement devices and patient monitors as a software feature.
CERENION C-TREND™ is a medical-grade software solution that works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The result is a simple index that measures the condition and function of the brain on a scale from 0 to 100.
The technology has the potential of improving both the quality and the cost of intensive care.
Easy interpretation
Fast setup
Continuous
monitoring

Our patented technology
in your devices

CERENION C-TREND™ will be integrated into a range of products made by our partner companies. The first partner product offerings featuring CERENION C-TREND™ technology are expected to be launched in 2019 in the European Union.
If you are interested about including our technology in your devices please contact us for more information.
"The technology Cerenion is developing has great potential in helping EEG specialists in faster and more accurate interpretation of EEG"
Chief Physician of Clinical Neurophysiology, Dr. Mika Kallio
"This invention will ease the day-to-day work at intensive care units"
Associate Chief Physician of Intensive Care, Dr. Jouko Laurila in newspapers Kaleva, Aamulehti, Turun Sanomat, Lapin Kansa, Forssan Lehti, Ilkka and Pohjalainen
"Outstanding example of research."
Professor Esa Mervaala, Council Chair, Vaajasalo Foundation in regards to our scientific publication recognized at NCCN & KES 2017
"There are currently no reliable methods for assessing brain function in the early stages of recovery from hypoxic, ischemic, or traumatic insults that might inform neurologic prognosis and therapy. Slow electroencephalographic waves induced by general anesthetics might provide a neurophysiologic signature of healthy brain function."
Hugh C. Hemmings, M.D., Ph.D., Handling Editor, Anesthesiology in regards to our scientific publication in the journal
Contact us
Visit us
Pages
OULU
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
FINLAND
VANTAA
Cerenion Oy
Teknobulevardi 3-5
01530 Vantaa
FINLAND
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Under no circumstances shall the information on this website be construed as an advertisement of any commercially available product. Cerenion™, Cerenion C-Trend™, C-Trend™, ''The next-generation brain monitoring company''™ and ''The pulse of the brain''™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2017.
Powered by:MetaVisual CMSDesign:Magee GroupMobile versionDesktop versionLog in© 2017 - 2019 Cerenion Oy